2196.HK | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Annual Balance Sheets

(In CNY)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	113.46 Billion	107.16 Billion	93.29 Billion	83.68 Billion	76.11 Billion	70.55 Billion
Total Current Assets	33.79 Billion	35.27 Billion	30.42 Billion	25.08 Billion	20.4 Billion	18 Billion
Cash And Short Term Investments	15.58 Billion	17.16 Billion	14.54 Billion	11.93 Billion	9.98 Billion	9.16 Billion
Cash and Cash Equivalents	13.69 Billion	16.24 Billion	10.3 Billion	9.96 Billion	9.53 Billion	8.54 Billion
Short Term Investments	1.88 Billion	928.53 Million	4.24 Billion	1.97 Billion	456.65 Million	616.12 Million
Net Receivables	9.96 Billion	10.79 Billion	9.51 Billion	7.25 Billion	5.87 Billion	5.25 Billion
Inventory	7.53 Billion	6.88 Billion	5.47 Billion	5.16 Billion	3.94 Billion	3.28 Billion
Other Current Assets	704.78 Million	429.14 Million	885.35 Million	733.35 Million	599.49 Million	295.95 Million
Total Non-Current Assets	79.67 Billion	71.88 Billion	62.86 Billion	58.6 Billion	55.71 Billion	52.54 Billion
Net PPE	22.23 Billion	16.02 Billion	13.28 Billion	13 Billion	11.08 Billion	9.12 Billion
Good Will And Intangible Assets	28.23 Billion	26.26 Billion	22.83 Billion	20.17 Billion	19.98 Billion	18.04 Billion
Good Will	10.85 Billion	10.33 Billion	9.39 Billion	8.67 Billion	9.01 Billion	8.85 Billion
Intangible Assets	17.37 Billion	15.92 Billion	13.43 Billion	11.49 Billion	10.96 Billion	9.19 Billion
Long-Term Investments	23.12 Billion	24.62 Billion	19.67 Billion	21.8 Billion	22.56 Billion	23.44 Billion
Tax Assets	624.47 Million	442.57 Million	265.58 Million	244.93 Million	196.09 Million	173.13 Million
Other Non Current Assets	5.45 Billion	4.53 Billion	6.8 Billion	3.37 Billion	1.89 Billion	1.76 Billion
Other Assets	1.00	1.00	-	-	-	-
Total Liabilities	56.85 Billion	53.05 Billion	44.91 Billion	37.7 Billion	36.91 Billion	36.95 Billion
Total Current Liabilities	33.75 Billion	33.29 Billion	29.3 Billion	24.87 Billion	17.43 Billion	17.92 Billion
Account Payables	6.15 Billion	6.28 Billion	5.06 Billion	3.28 Billion	2.39 Billion	2.33 Billion
Tax Payables	536.96 Million	929.83 Million	727.52 Million	564.73 Million	759.62 Million	478.9 Million
Short Term Debt	19.55 Billion	17.4 Billion	14.54 Billion	14.91 Billion	8.92 Billion	10.53 Billion
Deferred Revenue	7.91 Billion	1.00	8.17 Billion	6.61 Billion	5.86 Billion	478.9 Million
Other Current Liabilities	125.16 Million	9.61 Billion	1.52 Billion	54.56 Million	248.96 Million	4.57 Billion
Total Non Current Liabilities	23.09 Billion	19.75 Billion	15.6 Billion	12.82 Billion	19.48 Billion	19.03 Billion
Long-Term Debt	15.55 Billion	12.84 Billion	9.69 Billion	9.1 Billion	12.98 Billion	12.67 Billion
Deferred Revenue Non Current	639.39 Million	632.43 Million	512.8 Million	482.2 Million	417.34 Million	363.48 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	3.45 Billion	2.91 Billion	2.26 Billion	391.2 Million	3.08 Billion	3.09 Billion
Other Liabilities	1.00	-	1.00	1.00	1.00	-
Total Equity	56.61 Billion	54.1 Billion	48.37 Billion	45.98 Billion	39.2 Billion	33.59 Billion
Stock Holders Equity	45.68 Billion	44.58 Billion	39.19 Billion	36.99 Billion	31.88 Billion	27.97 Billion
Common Stock	2.67 Billion	2.67 Billion	2.56 Billion	2.56 Billion	2.56 Billion	2.56 Billion
Retained Earnings	24.54 Billion	23.21 Billion	21.03 Billion	17.5 Billion	15.12 Billion	12.77 Billion
Accumulated other comprehensive income	-1.3 Billion	-1.19 Billion	-1.26 Billion	-933.57 Million	-467.99 Million	-4.43 Billion
Common Stock Equity	45.68 Billion	44.58 Billion	39.19 Billion	36.99 Billion	31.88 Billion	27.97 Billion
Capital Lease Obligation	2.04 Billion	744.99 Million	648.36 Million	627.29 Million	410.18 Million	22.56 Million
Total Investments	25.01 Billion	25.54 Billion	23.92 Billion	23.77 Billion	23.02 Billion	24.05 Billion
Total Debt	35.1 Billion	30.24 Billion	24.24 Billion	24.01 Billion	21.9 Billion	23.2 Billion
Net Debt	21.41 Billion	14 Billion	13.93 Billion	14.05 Billion	12.37 Billion	14.66 Billion

Breakdown	2024 Q3	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3
Total Assets	115.26 Billion	115.53 Billion	113.74 Billion	113.46 Billion	113.46 Billion	110.76 Billion
Total Current Assets	34.52 Billion	34.79 Billion	33.83 Billion	33.79 Billion	33.79 Billion	34.91 Billion
Cash And Short Term Investments	15.63 Billion	16.1 Billion	15.02 Billion	15.58 Billion	15.58 Billion	15.8 Billion
Cash and Cash Equivalents	13.5 Billion	14.08 Billion	13 Billion	13.69 Billion	13.69 Billion	13.04 Billion
Short Term Investments	2.12 Billion	2.02 Billion	2.01 Billion	1.88 Billion	1.88 Billion	2.75 Billion
Net Receivables	967.83 Million	10.46 Billion	8.34 Billion	9.96 Billion	9.96 Billion	10.51 Billion
Inventory	7.43 Billion	7.51 Billion	7.29 Billion	7.53 Billion	7.53 Billion	7.96 Billion
Other Current Assets	10.49 Billion	722.81 Million	608.94 Million	704.78 Million	704.78 Million	626.8 Million
Total Non-Current Assets	80.73 Billion	80.73 Billion	79.9 Billion	79.67 Billion	79.67 Billion	75.85 Billion
Net PPE	21.86 Billion	21.55 Billion	21.45 Billion	22.23 Billion	22.23 Billion	20.05 Billion
Good Will And Intangible Assets	28.72 Billion	28.66 Billion	28.41 Billion	28.23 Billion	28.23 Billion	27.62 Billion
Good Will	10.8 Billion	10.88 Billion	10.85 Billion	10.85 Billion	10.85 Billion	11 Billion
Intangible Assets	17.92 Billion	17.78 Billion	17.56 Billion	17.37 Billion	17.37 Billion	16.62 Billion
Long-Term Investments	23.76 Billion	24.12 Billion	25.19 Billion	23.12 Billion	23.12 Billion	22.35 Billion
Tax Assets	791.14 Million	660.09 Million	621.8 Million	624.47 Million	624.47 Million	449.26 Million
Other Non Current Assets	5.58 Billion	5.72 Billion	4.22 Billion	5.45 Billion	5.45 Billion	5.36 Billion
Other Assets	-	-	-	1.00	1.00	-
Total Liabilities	56.07 Billion	56.67 Billion	56.21 Billion	56.85 Billion	56.85 Billion	54.78 Billion
Total Current Liabilities	37.51 Billion	37.4 Billion	33.6 Billion	33.75 Billion	33.75 Billion	34.5 Billion
Account Payables	6.34 Billion	6.52 Billion	6.13 Billion	6.15 Billion	6.15 Billion	6.25 Billion
Tax Payables	537.01 Million	520.97 Million	529.59 Million	536.96 Million	536.96 Million	765.71 Million
Short Term Debt	18.67 Billion	23.03 Billion	19.71 Billion	19.55 Billion	19.55 Billion	20.33 Billion
Deferred Revenue	6.36 Billion	7.72 Billion	7.64 Billion	7.91 Billion	7.91 Billion	7.8 Billion
Other Current Liabilities	6.13 Billion	119.57 Million	111.55 Million	125.16 Million	125.16 Million	106.52 Million
Total Non Current Liabilities	18.55 Billion	19.27 Billion	22.6 Billion	23.09 Billion	23.09 Billion	20.27 Billion
Long-Term Debt	8.87 Billion	11.75 Billion	15.19 Billion	15.55 Billion	15.55 Billion	13.04 Billion
Deferred Revenue Non Current	605.07 Million	613.68 Million	607.82 Million	639.39 Million	639.39 Million	606.84 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	5.61 Billion	3.49 Billion	3.38 Billion	3.45 Billion	3.45 Billion	3.13 Billion
Other Liabilities	-	-	1.00	1.00	1.00	1.00
Total Equity	59.19 Billion	58.86 Billion	57.53 Billion	56.61 Billion	56.61 Billion	55.98 Billion
Stock Holders Equity	47.3 Billion	46.96 Billion	46.34 Billion	45.68 Billion	45.68 Billion	45.91 Billion
Common Stock	2.67 Billion	2.67 Billion	2.67 Billion	2.67 Billion	2.67 Billion	2.67 Billion
Retained Earnings	25.82 Billion	25.04 Billion	25.15 Billion	24.54 Billion	24.54 Billion	24.41 Billion
Accumulated other comprehensive income	-	-1.19 Billion	15.6 Billion	-1.3 Billion	-1.3 Billion	15.94 Billion
Common Stock Equity	47.3 Billion	46.96 Billion	46.34 Billion	45.68 Billion	45.68 Billion	45.91 Billion
Capital Lease Obligation	2.21 Billion	1.95 Billion	2 Billion	2.04 Billion	2.04 Billion	814.83 Million
Total Investments	25.88 Billion	26.14 Billion	25.19 Billion	25.01 Billion	25.01 Billion	25.11 Billion
Total Debt	27.54 Billion	34.79 Billion	34.9 Billion	35.1 Billion	35.1 Billion	33.37 Billion
Net Debt	14.04 Billion	20.71 Billion	21.89 Billion	21.41 Billion	21.41 Billion	20.33 Billion

Balance Sheet Charts

Bombardier Inc.

BDRPF

Full Analysis

Annual Balance Sheets
Synlait Milk Limited

SML

Full Analysis

Annual Balance Sheets
European Lithium Limited

EUR

Full Analysis

Annual Balance Sheets
Excel Corporation

EXCC

Full Analysis

Annual Balance Sheets
Young & Co.'s Brewery, P.L.C.

YNGA

Full Analysis

Annual Balance Sheets
AXP Energy Limited

AXP

Full Analysis

Annual Balance Sheets

Global Stocks Search

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)

Annual Balance Sheets

Balance Sheet Charts

Bombardier Inc.

Synlait Milk Limited

European Lithium Limited

Excel Corporation

Young & Co.'s Brewery, P.L.C.

AXP Energy Limited